FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Drug Development Outsourcing Increasing: Tufts Study

The Tufts Center for the Study of Drug Development reports on the growth of contract research services as part of drug development worldwide.

Human Drugs

Apotex Recalls Contraceptive Due to Packaging Error

Apotex recalls four lots of drospirenone and ethinyl estradiol tablets because the contraceptive may contain defective blisters with incorrect tablet ...

Human Drugs

Andapharm CGMP Repeat Violations

FDA warns Andapharm about repeat and additional CGMP violations in its manufacturing of finished pharmaceuticals.

Human Drugs

Petition: Remove Boxed Warning from Contrast Agents

National and international ultrasound societies petition FDA to remove a black box warning from ultrasound contrast agent labels.

Federal Register

Comments Sought on Info Collection for IVD Study Guide

Federal Register notice: FDA seeks comments on an information collection extension for its Guidance on Informed Consent for In Vitro Diagnostic Device...

Federal Register

Info Collection on Influenza A Reagents Guide

Federal Register notice: FDA seeks comments on an information collection extension for its Guidance on Reagents for Detection of Specific Novel Influe...

Human Drugs

Comments on Surrogate Endpoint Table

Two stakeholders respond positively to an FDA guidance on developing a surrogate endpoint table.

Medical Devices

AdvaMed Glucose Test System Guidance Comments

AdvaMed praises two FDA draft guidances on blood glucose test systems.

Human Drugs

Fix Biologics Policy on Insulin: Senators

Four senators ask FDA to revise its new biosimilar pathway guidances as they apply to follow-on insulin products.

FDA General

Latest FDA Warning Letters

FDA releases its latest batch of Warning Letters that include Actavis Laboratories, AndaPharm, New Era Naturals and Vilvet Pharmaceuticals.